microRNAs as players and signals in the metastatic cascade: Implications for the development of novel anti-metastatic therapies

Published on Jun 1, 2017in Seminars in Cancer Biology11.09
· DOI :10.1016/J.SEMCANCER.2017.03.005
Paolo Gandellini25
Estimated H-index: 25
,
Valentina Doldi8
Estimated H-index: 8
,
Nadia Zaffaroni66
Estimated H-index: 66
Sources
Abstract
Abstract microRNAs (miRNAs) are small non-coding RNAs that negatively regulate gene expression at the post-transcriptional level. Increasing evidence emerging from human tumor preclinical models clearly indicates that specific miRNAs, collectively termed “metastamirs,” play a functional role in different steps of the metastatic cascade, by exerting either pro- or anti-metastatic functions, and behave as signaling mediators to enable tumor cell to colonize a specific organ. miRNAs also actively participate in the proficient interaction of cancer cells with tumor microenvironment, either at the primary or at the metastatic site. Circulating miRNAs, released by multiple cell types, following binding to proteins or encapsulation in extracellular vesicles, play a main role in this cross-talk by acting as transferrable messages. The documented involvement of specific miRNAs in the dissemination process has aroused interest in the development of miRNA-based strategies for the treatment of metastasis. Preclinical research carried out in tumor experimental models, using both miRNA replacement and miRNA inhibitory approaches, is encouraging towards translating miRNA-based strategies into human cancer therapy, based on the observed therapeutic activity in the absence of main toxicity. However, to accelerate their adoption in the clinic, further improvements in terms of efficacy and targeted delivery to the tumor are still necessary.
📖 Papers frequently viewed together
30 Citations
20095.31BioDrugs
2 Authors (Vivien Wang, Wei Wu)
123 Citations
20204.37Cells
7 Authors (Ilaria Conti, ..., Luca M. Neri)
20 Citations
References89
Newest
#1Muhammad Shaalan Beg (UTSW: University of Texas Southwestern Medical Center)H-Index: 19
#2Andrew Brenner (University of Texas Health Science Center at San Antonio)H-Index: 28
Last. David S. Hong (University of Texas MD Anderson Cancer Center)H-Index: 79
view all 10 authors...
Purpose Naturally occurring tumor suppressor microRNA-34a (miR-34a) downregulates the expression of >30 oncogenes across multiple oncogenic pathways, as well as genes involved in tumor immune evasion, but is lost or under-expressed in many malignancies. This first-in-human, phase I study assessed the maximum tolerated dose (MTD), safety, pharmacokinetics, and clinical activity of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumors. Patients and Methods Adult patients with so...
403 CitationsSource
Background The value of microRNAs (miRNAs) as novel targets for cancer therapy is now widely recognized. However, no information is currently available on the expression/functional role of miRNAs in diffuse malignant peritoneal mesothelioma (DMPM), a rapidly lethal disease, poorly responsive to conventional treatments, for which the development of new therapeutic strategies is urgently needed. Here, we evaluated the expression and biological effects of miR-34a—one of the most widely deregulated ...
27 CitationsSource
Extracellular microRNAs are released from cells both passively and actively. The presence of these microRNAs in the tumour microenvironment (TME) can significantly impact on the plasticity of cancer cells leading to the promotion of metastatic and angiogenic processes. These extracellular microRNAs can act not only on other cancer cells, but also cells present in the TME, such as immune cells, endothelial cells, fibroblasts, and others acting to subvert the host immune system and drive tumour pr...
46 CitationsSource
#1Olugbenga T. Awolaran (Oxford Brookes University)H-Index: 2
#2Susan A. Brooks (Oxford Brookes University)H-Index: 22
Last. Verna Lavender (Oxford Brookes University)H-Index: 7
view all 3 authors...
Abstract Metastasis accounts for most of the deaths from breast cancer and the preference of invasive breast cancer metastasising to bone has been widely reported. However, the biological basis of breast cancer osteotropism is not fully understood. This paper provides, for the first time, an integrative, systematic review of evidence of molecular factors that have functional roles in the homing of metastatic breast cancer to the bone. Pubmed, Web of Science and EBSCOhost were searched using keyw...
27 CitationsSource
#1Hanna Taipaleenmaki (UHH: University of Hamburg)H-Index: 9
#2Nicholas H. Farina (UVM: University of Vermont)H-Index: 10
Last. Jane B. Lian (UMMS: University of Massachusetts Medical School)H-Index: 124
view all 7 authors...
// Hanna Taipaleenmaki 1, 2 , Nicholas H. Farina 3 , Andre J. van Wijnen 1, 4 , Janet L. Stein 1, 3 , Eric Hesse 2, 5, * , Gary S. Stein 1, 3, * , Jane B. Lian 1, 3, * 1 Department of Cell Biology, University of Massachusetts Medical School, Worcester, MA, USA 2 Heisenberg-Group for Molecular Skeletal Biology, Department of Trauma, Hand & Reconstructive Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany 3 Department of Biochemistry & Cancer Center, University of Vermont Colle...
44 CitationsSource
#1Maitri Y. Shah (University of Texas MD Anderson Cancer Center)H-Index: 14
#2Alessandra Ferrajoli (University of Texas MD Anderson Cancer Center)H-Index: 85
Last. George A. Calin (University of Texas MD Anderson Cancer Center)H-Index: 140
view all 5 authors...
MicroRNAs (miRNAs) are an evolutionarily conserved class of small, regulatory non-coding RNAs that negatively regulate protein coding gene and other non-coding transcripts expression. miRNAs have been established as master regulators of cellular processes, and they play a vital role in tumor initiation, progression and metastasis. Further, widespread deregulation of microRNAs have been reported in several cancers, with several microRNAs playing oncogenic and tumor suppressive roles. Based on the...
223 CitationsSource
#1Lidong Sun (Moffitt Cancer Center)H-Index: 14
#2Jia Fang (Moffitt Cancer Center)H-Index: 16
Epithelial–mesenchymal transition (EMT) is an essential process for morphogenesis and organ development which reversibly enables polarized epithelial cells to lose their epithelial characteristics and to acquire mesenchymal properties. It is now evident that the aberrant activation of EMT is also a critical mechanism to endow epithelial cancer cells with migratory and invasive capabilities associated with metastatic competence. This dedifferentiation program is mediated by a small cohort of plei...
60 CitationsSource
#1Alexander A. Svoronos (Yale University)H-Index: 5
#2Donald M. Engelman (Yale University)H-Index: 96
Last. Frank J. Slack (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 87
view all 3 authors...
MicroRNAs (miRNA) are short, noncoding RNAs whose dysregulation has been implicated in most, if not all, cancers. They regulate gene expression by suppressing mRNA translation and reducing mRNA stability. To this end, there is a great deal of interest in modifying miRNA expression levels for the treatment of cancer. However, the literature is fraught with inconsistent accounts as to whether various miRNAs are oncogenic or tumor suppressive. In this review, we directly examine these inconsistenci...
357 CitationsSource
#1Bert Dhondt (UGent: Ghent University)H-Index: 11
#2Quentin Rousseau (UGent: Ghent University)H-Index: 3
Last. An Hendrix (UGent: Ghent University)H-Index: 21
view all 4 authors...
Extracellular RNA (exRNA) is functionally transferrable from donor to recipient cells and is protected from RNAses by electrostatic interactions with proteins or by membrane encapsulation. In addition to bioactive RNA, extracellular vesicles (EVs) contain intraluminal and membrane-associated proteins. The cellular context and fitness affect the composition of EVs and thus the outcome of the communication between the EV-producer and recipient cells. Adaptive communication through EVs is particula...
29 CitationsSource
#1Jamie N. Frediani (Children's Hospital Los Angeles)H-Index: 1
#2Muller Fabbri (SC: University of Southern California)H-Index: 59
MicroRNAs (miRNAs) are emerging as central players in shaping the biology of the Tumor Microenvironment (TME). They do so both by modulating their expression levels within the different cells of the TME and by being shuttled among different cell populations within exosomes and other extracellular vesicles. This review focuses on the state-of-the-art knowledge of the role of miRNAs in the complexity of the TME and highlights limitations and challenges in the field. A better understanding of the m...
42 CitationsSource
Cited By30
Newest
#1Paolo GandelliniH-Index: 25
Last. Nadia ZaffaroniH-Index: 66
view all 16 authors...
Active surveillance (AS) has evolved as a strategy alternative to radical treatments for very low risk and low-risk prostate cancer (PCa). However, current criteria for selecting AS patients are still suboptimal. Here, we performed an unprecedented analysis of the circulating miRNome to investigate whether specific miRNAs associated with disease reclassification can provide risk refinement to standard clinicopathological features for improving patient selection. The global miRNA expression profi...
Source
#1Erica Gentilin (UNIPD: University of Padua)H-Index: 2
#2Paolo Gandellini (University of Milan)H-Index: 25
Source
#1Martina Tassinari (University of Milan)
#2Sara N. Richter (UNIPD: University of Padua)H-Index: 33
Last. Paolo Gandellini (University of Milan)H-Index: 25
view all 3 authors...
Noncoding RNAs are functional transcripts that are not translated into proteins. They represent the largest portion of the human transcriptome and have been shown to regulate gene expression networks in both physiological and pathological cell conditions. Research in this field has made remarkable progress in the comprehension of how aberrations in noncoding RNA drive relevant disease-associated phenotypes; however, the biological role and mechanism of action of several noncoding RNAs still need...
2 CitationsSource
Ewing sarcoma (ES) is a malignant tumor that occurs mostly in children. However, the underlying mechanisms of ES are still unknown. Analyzing the results of two previous miRNA array reports, we found that miR-146b-5p might be an onco-miRNA in ES progression. To test this hypothesis, we detected the expression levels of miR-146b-5p by real-time PCR and observed the effects of miR-146b-5p on the progression of ES cells by CCK8 and transwell assays. Bioinformatics and luciferase assays were used to...
1 CitationsSource
#1Kefeng Lv (Southern Medical University)
#2Yuhua Liu (Southern Medical University)
Last. Haifeng Miao (Southern Medical University)
view all 6 authors...
Backgrounds Parkinson's disease (PD) is a common age-related neurodegenerative disorder worldwide. This research aimed to investigate the effects and mechanism underlying long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) in PD. Methods SK-N-SH and SK-N-BE cells were treated with MPP+ to establish the MPP+-stimulated cell model of PD, and MALAT1 expression was determined. Then, the effects of MALAT1 depletion on cell proliferation and apoptosis were determined in...
Source
#1Liaoran NiuH-Index: 1
#2Wanli YangH-Index: 8
Last. Daiming Fan (Fourth Military Medical University)H-Index: 88
view all 13 authors...
Abstract Colorectal cancer (CRC), ranking as the third commonest cancer, leads to extremely high rate of mortality. Metastasis is the major cause of poor outcome in CRC. When metastasis occurs, 5-year survival rates of patients decrease sharply, and strategies to enhance patient’s lifetime seem limited. MicroRNAs(miRNAs) are evolutionarily conserved small non-coding RNAs that are significantly involved in manipulation of CRC malignant phenotypes, including proliferation, invasion, and metastasis...
2 CitationsSource
#1Martina Tassinari (University of Milan)
#2Paolo Gandellini (University of Milan)H-Index: 25
Cancer development and progression are not solely cell-autonomous and genetically driven processes. Dynamic interaction of cancer cells with the surrounding microenvironment, intended as the chemical/physical conditions as well as the mixture of non-neoplastic cells of the tumor niche, drive epigenetic changes that are pivotal for the acquisition of malignant traits. Cancer-associated fibroblasts (CAF), namely fibroblasts that, corrupted by cancer cells, acquire a myofibroblast-like reactive phe...
Source
#1Olga A. Sukocheva (Flinders University)H-Index: 19
#2Elena Lukina (Flinders University)H-Index: 2
Last. Gjumrakch Aliev (RAS: Russian Academy of Sciences)H-Index: 53
view all 6 authors...
Abstract Breast cancer (BC) cell de-sensitization to Tamoxifen (TAM) or other selective estrogen receptor (ER) modulators (SERM) is a complex process associated with BC heterogeneity and the transformation of ER signalling. The most influential resistance-related mechanisms include modifications in ER expression and gene regulation patterns. During TAM/SERM treatment, epigenetic mechanisms can effectively silence ER expression and facilitate the development of endocrine resistance. ER status is ...
4 CitationsSource
#1Xue Yang (CPU: China Pharmaceutical University)H-Index: 6
#2Fang Gao (CPU: China Pharmaceutical University)H-Index: 4
Last. Minjie Sun (CPU: China Pharmaceutical University)H-Index: 27
view all 10 authors...
Abstract Invasion and metastasis of tumor cells is one of the major obstacles in cancer therapy. The process of tumor metastasis and diffusion is coordinated by multiple pathways associated with chemokine signals and migration microenvironment. In our previous work, chemokine CXC receptor 4 (CXCR4) antagonists showed significant anti-metastatic effects by blocking the CXCR4/stromal cell-derived factor-1(SDF-1) axis in pancreatic cancer and breast cancer. Here, we proposed to achieve migration ch...
1 CitationsSource
Abstract Osteosarcoma is the most common malignant bone tumor. Early diagnosis remains a major challenge, mainly because of the lack of specific biomarkers. We performed miRNAs expression analysis through qPCR in affected and paired healthy bone derived from osteosarcoma patients. Hierarchical clustering using the top ten miRNAs with differential expression showed two main clusters. One integrated by patients with the presence of metastasis or relapse and the other without these complications. F...
1 CitationsSource